Literature DB >> 15804918

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Neelum T Aggarwal1, Robert S Wilson, Todd L Beck, Julia L Bienias, Elizabeth Berry-Kravis, David A Bennett.   

Abstract

Possession of one or more copies of the apolipoprotein E (APOE) epsilon4 allele is a known risk factor for Alzheimer's disease (AD), but it is uncertain whether the epsilon4 allele is associated with disease incidence among persons with mild cognitive impairment (MCI). We addressed this issue with data from the Religious Orders Study. Participants were 181 older Catholic clergy members who met criteria for MCI based on a uniform structured clinical evaluation; 56 (30.9%) had at least one epsilon4 allele. Clinical evaluations, which included clinical classification of dementia and AD, were repeated annually. During a mean of 5.7 years of observation, 79 persons (43.6%) developed AD. In a proportional hazards model that controlled for age, sex, and education, possession of an epsilon4 allele was associated with a 93% increase in the risk of developing Alzheimer's disease (95% CI; 1.02, 2.63). There was a marginally significant reduction in the effect of epsilon4 in older compared to younger participants (p=.053). The results suggest that possession of an epsilon4 allele does increase risk of AD in persons with MCI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804918     DOI: 10.1080/13554790490903038

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  26 in total

Review 1.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.

Authors:  May A Beydoun; Adel Boueiz; Marwan S Abougergi; Melissa H Kitner-Triolo; Hind A Beydoun; Susan M Resnick; Richard O'Brien; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

Review 3.  Challenges in clinical research on Alzheimer's disease: Leon Thal's legacy.

Authors:  Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

4.  Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons.

Authors:  Aron S Buchman; Patricia A Boyle; Robert S Wilson; Todd L Beck; Jeremiah F Kelly; David A Bennett
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

5.  Poorer Financial and Health Literacy Among Community-Dwelling Older Adults With Mild Cognitive Impairment.

Authors:  S Duke Han; Patricia A Boyle; Bryan D James; Lei Yu; David A Bennett
Journal:  J Aging Health       Date:  2015-04-22

6.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

7.  Exploratory analysis of seven Alzheimer's disease genes: disease progression.

Authors:  Agustín Ruiz; Isabel Hernández; Maiteé Ronsende-Roca; Antonio González-Pérez; Emma Rodriguez-Noriega; Reposo Ramírez-Lorca; Ana Mauleón; Concha Moreno-Rey; Lucie Boswell; Larry Tune; Sergi Valero; Montserrat Alegret; Javier Gayán; James T Becker; Luis Miguel Real; Lluís Tárraga; Clive Ballard; Michael Terrin; Stephanie Sherman; Haydeh Payami; Oscar L López; Jacobo E Mintzer; Mercè Boada
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

Review 8.  Mild cognitive impairment: ten years later.

Authors:  Ronald C Petersen; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2009-12

9.  The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Jeremiah F Kelly; David A Bennett
Journal:  Neuroepidemiology       Date:  2009-11-11       Impact factor: 3.282

10.  Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment.

Authors:  Curtis Tatsuoka; Huiyun Tseng; Judith Jaeger; Ferenc Varadi; Mark A Smith; Tomoko Yamada; Kathleen A Smyth; Alan J Lerner
Journal:  Alzheimers Res Ther       Date:  2013-03-06       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.